IMO announces leadership transition to support next chapter of growth and innovation

Intelligent Medical Objects, Inc. (IMO), the market leader in terminology services for healthcare IT, announced today that Chairman, CEO and Co-Founder, Frank Naeymi-Rad, will transition from CEO to the new role of Chief Innovator and continue as Chairman of the Board of the company. Ann Barnes, a seasoned technology and healthcare executive and former President and CEO of MedData Inc., will assume the role of CEO of IMO effective June 15, 2018.
Share on facebook
Share on twitter
Share on linkedin
Share on email
interface clinical services

Since its growth capital investment from Warburg Pincus in 2016, IMO has been on a trajectory of growth and innovation. Sales of its flagship Problem IT® product and the release of the IMO 2.0 innovation platform, together with the evolution of IMO’s industry-leading clinical interface terminology services, have spurred strong business performance. IMO 2.0 unlocked the ability for IMO customers to rapidly innovate on its platform with regular updates that deliver the latest in terminology services and process automation.

“There couldn’t be a better time to have Ann join our leadership team,” said Dr. Naeymi-Rad. “Her vision and experience with health IT solutions supporting provider revenue cycle management align perfectly with our customers’ need to have clinical documentation and transactions integrated with revenue cycle services. The key value that we strive to deliver to all of our customers is transparency in care documentation — the source of “patient truth.” By providing this core value and supporting coding requirements, we help position our electronic health record (EHR) partners for financial growth and stability while supporting our own growth trajectory.”

Ann Barnes joined MedData in 2008, driving the growth and expansion of MedData services to hospitals. Her knowledge and passion for the provider side of the business, as well as her focus on the patient, will be a strong addition to IMO. MedData, a MEDNAX company, provides technology-enabled management solutions for hospitals and health systems that serve the entire patient, payer, and facility financial lifecycle, serving over 10,000 physicians and more than 3,000 facilities nationwide. She is a graduate of the University of the Pacific in California.

“I am looking forward to working together with Frank and the rest of the IMO team to ensure a smooth transition for our company and customers,” said Barnes. “There is an amazing amount
of talent here, which we will use to maintain the momentum underway as Frank continues to be a visionary for IMO and the industry in his new role as Chief Innovator.”

IMO’s current phase of growth and innovation has led Dr. Naeymi-Rad to envision initiatives to accelerate the best new ideas in healthcare that use clinical interface terminology to improve the healthcare experience and enable value-based care delivery. “These initiatives align well with our concept of a semantic highway linking all stakeholders in the healthcare ecosystem onto a common terminology standard. I look forward to leading these efforts,” said Dr. Naeymi-Rad.

About Intelligent Medical Objects (IMO)

At IMO, we are dedicated to powering care as you intended, through a platform that is intelligent, intuitive, and intentional. Used by more than 4,500 hospitals and 500,000 physicians daily, IMO’s clinical interface terminology (CIT) forms the foundation for healthcare enterprise needs including effective management of EHR problem lists, accurate documentation, and the mapping of over 2.4 million clinician-friendly terms across 24 different code systems.

We offer a portfolio of products that includes terminologies and value sets that are clinically vetted, always current, and maintenance-free. This aligns to provider organizations’ missions, EHR platforms’ inherent power, and the evolving vision of the healthcare industry while ensuring accurate care documentation and administrative codes. So clinicians can get back to being clinicians, health systems can get reimbursed, and patients can more easily engage in their own care. As intended.

© 2019 Intelligent Medical Objects, Inc. All rights reserved.

Share on facebook
Share on twitter
Share on linkedin
Share on email

Related Ideas

Webinar: ICD-10-CM 2020 Updates and Regulatory Readiness

The 2020 regulatory release is right around the corner. Join us on Thursday, September 19th from 12:00 PM – 1:00 PM CST for a comprehensive webinar on the ICD-10-CM 2020 code updates that go into effect on October 1st. Hear from IMO’s top coding professionals and thought leaders, June Bronnert, MSHI, RHIA, CCS, CCS-P, Theresa Rihanek, MHA, RHIA, CCS, and Julie Glasgow, MD. This webinar will review additions, deletions and other revisions to the 2020 ICD-10-CM code set.

Read More